These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17970666)

  • 1. Controlled release systems of angiogenic growth factors for cardiovascular diseases.
    Esaki J; Marui A; Tabata Y; Komeda M
    Expert Opin Drug Deliv; 2007 Nov; 4(6):635-49. PubMed ID: 17970666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis for myocardial ischemia.
    Rosinberg A; Khan TA; Sellke FW; Laham RJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):271-83. PubMed ID: 15151475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic angiogenesis: translating experimental concepts to medically relevant goals.
    Emanueli C; Madeddu P
    Vascul Pharmacol; 2006 Nov; 45(5):334-9. PubMed ID: 17008132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis: a "breakthrough" technology in cardiovascular medicine.
    Isner JM
    J Invasive Cardiol; 2000 Feb; 12 Suppl A():14A-7A. PubMed ID: 10731291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
    Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(5):219-29. PubMed ID: 18708823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in the human heart: gene and cell therapy.
    Tirziu D; Simons M
    Angiogenesis; 2005; 8(3):241-51. PubMed ID: 16308736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging technologies for enabling proangiogenic therapy.
    Roy RS; Roy B; Sengupta S
    Nanotechnology; 2011 Dec; 22(49):494004. PubMed ID: 22101316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.
    Ylä-Herttuala S; Markkanen JE; Rissanen TT
    Trends Cardiovasc Med; 2004 Nov; 14(8):295-300. PubMed ID: 15596105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease.
    Shah PB; Losordo DW
    Adv Genet; 2005; 54():339-61. PubMed ID: 16096018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
    Losordo DW; Dimmeler S
    Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038
    [No Abstract]   [Full Text] [Related]  

  • 13. A balancing act: therapeutic approaches for the modulation of angiogenesis.
    Springer ML
    Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction--an obstacle of therapeutic angiogenesis.
    Sun L; Bai Y; Du G
    Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combating cardiovascular disease with angiogenic therapy.
    Jacobs J
    Drug Discov Today; 2007 Dec; 12(23-24):1040-5. PubMed ID: 18061883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing the logic of therapeutic angiogenesis for ischemic disease.
    Emanueli C; Madeddu P
    Trends Mol Med; 2005 May; 11(5):207-16. PubMed ID: 15882608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of erythropoietin using biodegradable gelatin hydrogel microspheres persistently improves lower leg ischemia.
    Li L; Okada H; Takemura G; Esaki M; Kobayashi H; Kanamori H; Kawamura I; Maruyama R; Fujiwara T; Fujiwara H; Tabata Y; Minatoguchi S
    J Am Coll Cardiol; 2009 Jun; 53(25):2378-88. PubMed ID: 19539150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological approaches to ischemic tissue repair: gene- and cell-based strategies.
    Roncalli J; Tongers J; Renault MA; Losordo DW
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):653-68. PubMed ID: 18510483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II angiogenesis stimulators.
    Ribatti D; Baiguera S
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1157-66. PubMed ID: 23790062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factors for therapeutic angiogenesis in peripheral arterial disease.
    Jones WS; Annex BH
    Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.